Infliximab (Anti–Tumor Necrosis Factor α Antibody)
Open Access
- 1 December 2001
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 137 (12) , 1571-1574
- https://doi.org/10.1001/archderm.137.12.1571
Abstract
Case Report from JAMA Dermatology — Infliximab (Anti–Tumor Necrosis Factor α Antibody) — A Novel, Highly Effective Treatment of Recalcitrant Subcorneal Pustular Dermatosis (Sneddon-Wilkinson Disease)Keywords
This publication has 1 reference indexed in Scilit:
- Receptor Binding and Activation of Polymorphonuclear Neutrophils by Tumor Necrosis Factor-AlphaJournal of Leukocyte Biology, 1987